Beigene

Developer of targeted and immune-oncology drugs against cancer

placeCambridge, Massachusetts, United States calendar_todayFounded 2010 groups1,090 employees language beigene.com

Registered entities

Innovation

185 patent families (47 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 9,295 times.

YearFilings
201511
201616
201717
201824
201934
202037
202158
202275
202383
202494
202551
20264

Investor mix

15 investors on record; lead investors include Hillhouse.

Investor typeCountShare
Venture capital427%
Private equity427%
Bank & private debt17%
Other / undisclosed640%

Hiring activity

Hires frequently

121 roles tracked across 7 of the last 12 months

14 May 2026 · Senior Associate, Regulatory Affairs (US)

6 May 2026 · Associate Director, Regulatory Affairs

22 Apr 2026 · Senior Director, Integrated Insights – Europe · Basel

22 Apr 2026 · Associate Director, Commercial Insights and Analytics · Basel

10 Mar 2026 · Director, Business Intelligence · Basel

Based on job postings tracked across public sources.

Coming soon